OLMA · Olema Pharmaceuticals, Inc.
$11.59
+0.24 (+2.11%)
At close · Jul 21
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$1.01B
Shares
87.35M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 2 | $12.20 | $24 |
| 2026-06-29 | 363 | $11.39 | $4,135 |
| 2026-06-26 | 33 | $11.43 | $377 |
| 2026-05-22 | 2,790 | $14.06 | $39,227 |
| 2026-05-18 | 7,229 | $13.59 | $98,242 |
| 2026-05-13 | 62 | $13.97 | $866 |
| 2026-05-08 | 4,009 | $15.13 | $60,656 |
| 2026-05-07 | 2,358 | $15.19 | $35,818 |
| 2026-05-06 | 140 | $14.64 | $2,050 |
| 2026-05-05 | 3,620 | $14.63 | $52,961 |
| 2026-05-04 | 8,445 | $14.32 | $120,932 |
| 2026-04-28 | 326 | $15.29 | $4,985 |
Showing 1–12 of 12 settlements
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
13 filings
13 filers
Visit website
Investor relations